These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30774659)

  • 1. Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis.
    Vacante F; Senesi P; Montesano A; Paini S; Luzi L; Terruzzi I
    Int J Endocrinol; 2019; 2019():7570146. PubMed ID: 30774659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
    Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
    Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
    Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
    Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
    Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.
    Abdelmonsif DA; Sultan AS; El-Hadidy WF; Abdallah DM
    Mol Diagn Ther; 2018 Feb; 22(1):115-127. PubMed ID: 29094287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis.
    Reverchon M; Cornuau M; Cloix L; Ramé C; Guerif F; Royère D; Dupont J
    Mol Hum Reprod; 2013 May; 19(5):313-26. PubMed ID: 23315983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction.
    He B; Dai L; Zhang X; Chen D; Wu J; Feng X; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Int J Biol Sci; 2018; 14(13):1845-1858. PubMed ID: 30443188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.
    Hung TM; Ho CM; Liu YC; Lee JL; Liao YR; Wu YM; Ho MC; Chen CH; Lai HS; Lee PH
    PLoS One; 2014; 9(2):e89446. PubMed ID: 24586785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6.
    He AD; Xie W; Song W; Ma YY; Liu G; Liang ML; Da XW; Yao GQ; Zhang BX; Gao CJ; Xiang JZ; Ming ZY
    Sci Rep; 2017 Jun; 7(1):3989. PubMed ID: 28638139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines].
    Yao NH; Yao DF; Dong ZZ; Yan XD; Chen J; Yao M; Wang L; Yan MJ
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):376-80. PubMed ID: 24025141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.
    Wang Y; Chen X; Yao N; Gong J; Cao Y; Su X; Feng X; Tao M
    J Gastrointest Oncol; 2022 Feb; 13(1):355-367. PubMed ID: 35284123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
    Zhang W; Liu K; Liu S; Ji B; Wang Y; Liu Y
    Tumour Biol; 2015 Dec; 36(12):9779-88. PubMed ID: 26156803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatocellular carcinoma growth by antisense oligonucleotides to type I insulin-like growth factor receptor in vitro and in an orthotopic model.
    Lin RX; Wang ZY; Zhang N; Tuo CW; Liang QD; Sun YN; Wang SQ
    Hepatol Res; 2007 May; 37(5):366-75. PubMed ID: 17441810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
    Liu L; Qin S; Zheng Y; Han L; Zhang M; Luo N; Liu Z; Gu N; Gu X; Yin X
    Cancer Biol Ther; 2017 Mar; 18(3):166-176. PubMed ID: 28368741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.
    Chen HP; Shieh JJ; Chang CC; Chen TT; Lin JT; Wu MS; Lin JH; Wu CY
    Gut; 2013 Apr; 62(4):606-15. PubMed ID: 22773548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.